Mode
Text Size
Log in / Sign up
N/A N=22 Other

Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease

Parkinson Disease

Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcome: Primary: Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Feedback — 85.44 revolutions per minute (rpm) — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Virtual reality bicycling (Other)
Age
Adult, Older Adult · 45+ yrs
Sex
All
Sponsor
Rutgers, The State University of New Jersey
Primary completion
Feb 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Feedback
85.44 <0.001 sig
PRIMARY
Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Self-Competition
92.97
PRIMARY
Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Other-Competition
93.83
PRIMARY
Motivation (Intrinsic Motivation Inventory) - Feedback
6.06 0.111
PRIMARY
Motivation (Intrinsic Motivation Inventory) - Self-Competition
6.13
PRIMARY
Motivation (Intrinsic Motivation Inventory) - Other-Competition
6.11
PRIMARY
Cardiovascular Intensity (Heart Rate, Beats Per Minute) - Feedback
109.26 <0.001 sig
PRIMARY
Cardiovascular Intensity (Heart Rate, Beats Per Minute) - Self-Competition
115.41
PRIMARY
Cardiovascular Intensity (Heart Rate, Beats Per Minute) - Other-Competition
114.42
PRIMARY
Visual Attention (Infrared Eye-tracking Data Representing Gaze Positions in a 3D Coordinate Plane to be Used in Calculating Dwell Time in Regions of Interest in the Virtual Simulation) - Feedback
76.70 > 0.05
PRIMARY
Visual Attention (Infrared Eye-tracking Data Representing Gaze Positions in a 3D Coordinate Plane to be Used in Calculating Dwell Time in Regions of Interest in the Virtual Simulation) - Self-Competition
79.20
PRIMARY
Visual Attention (Infrared Eye-tracking Data Representing Gaze Positions in a 3D Coordinate Plane to be Used in Calculating Dwell Time in Regions of Interest in the Virtual Simulation) - Other-Competition
77.89
SECONDARY
Rating of Perceived Exertion - Feedback (Start)
8.43
SECONDARY
Rating of Perceived Exertion - Feedback (Middle)
12.62
SECONDARY
Rating of Perceived Exertion - Feedback (End)
14.0 0.004 sig
SECONDARY
Rating of Perceived Exertion - Self-Competition (Start)
8.67
SECONDARY
Rating of Perceived Exertion - Self-Competition (Middle)
13.81
SECONDARY
Rating of Perceived Exertion - Self-Competition (End)
15.57
SECONDARY
Rating of Perceived Exertion - Other-Competition (Start)
9.0
SECONDARY
Rating of Perceived Exertion - Other-Competition (Middle)
13.57
SECONDARY
Rating of Perceived Exertion - Other-Competition (End)
15.0
SECONDARY
Competitiveness (Multidimensional Competitive Orientation Inventory)
2.4; 2.3; 2.0; 4.3
SECONDARY
Ranking of Perceived Effort
11; 8; 2 > 0.05
SECONDARY
Ranking of Enjoyment
8; 7; 6 > 0.05
SECONDARY
Audio Recordings of Exercise Experience

Summary

This study has three objectives about persons with Parkinson's Disease during bicycling: 1. Determine the effect of visual feedback and competition during virtual bicycling on neuromuscular and cardiovascular intensity 2. Determine the effect of visual-feedback and competition during virtual bicycling on the user experience of motivation, enjoyment & perception of exercise intensity 3. Determine if attention differs during visual feedback compared to competition virtual bicycling

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Parkinson's disease following the UK Brain Bank Diagnostic Criteria,
  • Hoehn and Yahr stages II-III,
  • 45-80 years old,
  • Able to ride a stationary upright bicycle,
  • Able to sign informed consent.

Exclusion Criteria

  • Have a recent history of severe heart disease, severe lung disease, uncontrolled diabetes, traumatic brain injury or neurological disorder other than Parkinson Disease,
  • Are unable to follow directions or sign a consent form,
  • Do not have adequate vision or hearing ability to see or hear a television,
  • Have unstable medical condition or musculoskeletal disorder such as severe arthritis, recent knee surgery, hip surgery, or any other condition that the investigators determine would impair the ability to ride the bicycle,
  • Have any other medical condition that prevents bicycling,
  • Have moderate depression (score of 9 or more on GDS screening tool).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05160025). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search